FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...